Porphyria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
Conditions:   Anti-Psychotic;   Management of Manifestations of Psychotic Disorders;   Treatment of Schizophrenia;   Control Nausea and Vomiting;   Relief of Restlessness and Apprehension Before Surgery;   Acute Intermittent Porphyria;   Adjunct in the Treatment of Tetanus;   Control Manife stations of the Manic Type of Mani-depressive Illness;   Relief of Intractable Hiccups Intervention:   Drug: Chlorpromazine Hydrochloride Sponsors:   Cycle Pharmaceuticals Ltd.;   Parexel Not yet recruiting - verified October 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2016 Category: Research Source Type: clinical trials